Cargando…
Somatostatin receptor type 2 as a radiotheranostic PET reporter gene for oncologic interventions
Reporter gene systems can serve as therapy targets. However, the therapeutic use of reporters has been limited by the challenges of transgene delivery to a majority of cancer cells. This study specifically assesses the efficacy of targeting human somatostatin receptor subtype 2 (hSSTR2) with peptide...
Autores principales: | Heidari, Pedram, Kunawudhi, Anchisa, Martinez-Quintanilla, Jordi, Szretter, Alicia, Shah, Khalid, Mahmood, Umar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6010996/ https://www.ncbi.nlm.nih.gov/pubmed/29930736 http://dx.doi.org/10.7150/thno.24017 |
Ejemplares similares
-
Radiotheranostics Practice in India- Advancing to Precision Oncology
por: Kumar, Rakesh, et al.
Publicado: (2022) -
Radiotheranostic Agents in Hematological Malignancies
por: Caers, Jo, et al.
Publicado: (2022) -
A case report of hyperfunctioning metastatic thyroid cancer and rare I-131 avid liver metastasis
por: Kunawudhi, Anchisa, et al.
Publicado: (2016) -
(11)C-Choline and FDG PET/CT Imaging of Primary Cholangiocarcinoma: A Comparative Analysis
por: Chotipanich, Chanisa, et al.
Publicado: (2015) -
Evaluation of Imaging Windows for Tau PET Imaging Using (18)F-PI2620 in Cognitively Normal Individuals, Mild Cognitive Impairment, and Alzheimer’s Disease Patients
por: Chotipanich, Chanisa, et al.
Publicado: (2020)